+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Manufacturing Execution System In Life Sciences Market Analysis & Forecast to 2024-2034

  • PDF Icon

    Report

  • 200 Pages
  • May 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5968527
The global manufacturing execution system in life sciences market accounted for USD 2.78 billion in 2023 and is expected to reach at USD 9.91 billion by 2034 with a CAGR of 12.25% during the forecast period 2024-2034. Surge in regulatory adherence, growing demand for real-time data & analytics, expansion of the biopharmaceutical industry, rapid technological progress, rising adoption of digitization, heightened intricacy in pharmaceutical & biotechnology production, escalating necessity for accurate data handling, increased interest in personalized medicine, growing demand for cutting-edge treatments, surge in merger & acquisition (M&A) undertakings among key market players, and increase in the introduction of advanced manufacturing execution systems in life sciences are some of the key factors boosting the market growth.

Increase in the introduction of advanced manufacturing execution systems in life sciences is predicted to boost the market growth during the forecast period. The integration of Manufacturing Execution System (MES) is becoming increasingly pivotal in the life science sector, contributing to enhancements in efficiency, compliance, and innovation throughout production operations. Industries within life sciences, such as pharmaceuticals and biotechnology, demand a refined strategy for managing manufacturing processes. MES offers comprehensive and data-oriented solutions that play a crucial role in fulfilling and surpassing regulatory standards, mitigating risks, and maintaining product quality. For instance, in January 2022, POMS Corporation introduced new MES Dashboards and Batch Records tailored for drug manufacturers operating in the pharmaceutical, biotechnology, and cell and gene sectors. This unveiling is anticipated to provide notable advantages to manufacturers within these industries.

By solution, software was the highest revenue-grossing segment in the global manufacturing execution system in life sciences market in 2023 owing to the growing focus on ensuring data integrity, traceability, & regulatory adherence within the life sciences sector, rising need for comprehensive visibility throughout the entire manufacturing lifecycle, uptick in research & development initiatives, life sciences companies are increasingly investing in Manufacturing Execution System (MES) solutions that provide seamless data integration and analytics capabilities, and rising collaborations among market participants. For instance, in September 2023, Korber and Endeavor have joined forces to streamline the integration of Werum PAS-X MES with SAP's ERP platform. This collaboration is designed to offer a seamless solution to businesses utilizing both software platforms for their operations. Additionally, services is predicted to grow at the fastest CAGR during the forecast period owing to the rising trend toward digitalization in manufacturing processes, increased focus on safeguarding data integrity & cybersecurity. MES service providers specialize in implementing strong security measures to safeguard sensitive information and ensure adherence to industry regulations.

By deployment, on-premise was the highest revenue-grossing segment in the global manufacturing execution system in life sciences market in 2023 owing to the rising trend in the introduction of advanced systems. On-premise solutions provide enhanced control over data security and privacy, mitigating worries regarding sensitive information and intellectual property. Furthermore, life science firms frequently handle extensive volumes of intricate data produced during manufacturing, encompassing essential quality control parameters and batch tracking details. On-premise MES solutions deliver the requisite computing power and storage capability to effectively manage such data-intensive procedures. Additionally, cloud/web-based is predicted to grow at the fastest CAGR during the forecast period owing to the increase in demand for smooth integration with current enterprise resource planning (ERP) systems, laboratory information management systems (LIMS), & other legacy applications, particularly within the life science sector. Leading market players are undertaking initiatives to address this growing need. For instance, in April 2023, GE Digital, a key division of GE Vernova's energy portfolio and a prominent provider of innovative solutions in the Manufacturing Execution System (MES) market, has been recognized by Gartner for the second year in a row as a Leader in the Magic Quadrant for Manufacturing Execution Systems. This acknowledgment is attributed to its Proficy Smart Factory (MES) software solution.

By end-user, pharmaceutical & biotechnology companies was the highest revenue-grossing segment in the global manufacturing execution system in life sciences market in 2023 owing to the increase in partnerships among industry participants and growing introduction of innovative systems. MES solutions empower companies to oversee production lines meticulously, thereby maintaining their competitiveness. Biotechnology firms also find value in MES for efficiently overseeing the intricate processes associated with manufacturing biologics and personalized medications. For instance, in October 2023, Quadrant Knowledge Solutions released the SPARK Matrix analysis report on the worldwide MES - Process & Batch Market. Additionally, medical device companies is predicted to grow at the fastest CAGR during the forecast period. Producing medical devices poses unique obstacles that companies must overcome to remain competitive. This entails striking a careful equilibrium between reducing costs and ensuring regulatory adherence, all while maintaining a steady output of top-notch products.

North America region is anticipated for the highest revenue share during the forecast period owing to the rise in technological progress, widespread implementation of software solutions in life science manufacturing, growing uptake of integrated laboratory automation solutions, and increase in partnerships among industry participants. For instance, in January 2024, CGI Group, a Canadian IT consulting company, revealed a partnership with Korber to utilize its Werum PAS-X MES Suite for serving pharmaceutical clients. This MES suite, designed specifically for the pharmaceutical and biotechnology sectors, is offered as either an on-premise or cloud-based solution. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in the number of pharmaceutical companies, the prominence of key market players, uptick in the adoption of MES solutions to digitize production processes & improve operational efficiency, growing demand for high-quality drugs, increasing necessity to ramp up pharmaceutical production, and surge in the introduction of advanced systems. For instance, in February 2023, AVEVA Group Limited, a leading industrial software company, introduced the latest version of its AVEVA Manufacturing Execution System. The objective of this new release is to streamline the implementation of multi-site MES solutions and lower the associated expenses and intricacies. With its most recent iteration, AVEVA MES facilitates quicker and more effective adoption of best practices, potentially resulting in enhanced operational efficiency and sustainability.

This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Solution, Deployment, and End-user
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of Top 10+ Major Market Players

Segmentation: Manufacturing Execution System In Life Sciences Market Report 2023 - 2034

Manufacturing Execution System In Life Sciences Market Analysis & Forecast by Solution 2023 - 2034 (Revenue USD Bn)

  • Services
  • Software

Manufacturing Execution System In Life Sciences Market Analysis & Forecast by Deployment 2023 - 2034 (Revenue USD Bn)

  • Cloud/Web-Based
  • On-Premise
  • Hybrid

Manufacturing Execution System In Life Sciences Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)

  • Medical Device Companies
  • Pharmaceutical and Biotechnology Companies
  • Others
  • CDMOs
  • CROs

Manufacturing Execution System In Life Sciences Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Manufacturing Execution System In Life Sciences Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Manufacturing Execution System In Life Sciences Market: Solution Estimates & Trend Analysis
7.1. Solution Segment Opportunity Analysis
7.2. Services
7.2.1. Services Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Software
7.3.1. Software Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Manufacturing Execution System In Life Sciences Market: Deployment Estimates & Trend Analysis
8.1. Deployment Segment Opportunity Analysis
8.2. Cloud/Web-Based
8.2.1. Cloud/Web-Based Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. On-Premise
8.3.1. On-Premise Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Hybrid
8.4.1. Hybrid Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Manufacturing Execution System In Life Sciences Market: End-user Estimates & Trend Analysis
9.1. End-user Segment Opportunity Analysis
9.2. Medical Device Companies
9.2.1. Medical Device Companies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Pharmaceutical and Biotechnology Companies
9.3.1. Pharmaceutical and Biotechnology Companies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Others
9.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4.2. CDMOs
9.4.2.1. CDMOs Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4.3. CROs
9.4.3.1. CROs Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Manufacturing Execution System In Life Sciences Market
11.1. North America Manufacturing Execution System In Life Sciences Market
11.1.1. North America Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Manufacturing Execution System In Life Sciences Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
11.1.4. North America Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
11.1.5. North America Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Manufacturing Execution System In Life Sciences Market
11.2.1. U.S. Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Manufacturing Execution System In Life Sciences Market
11.3.1. Canada Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12. Europe Global Manufacturing Execution System In Life Sciences Market
12.1. Europe Global Manufacturing Execution System In Life Sciences Market
12.1.1. Europe Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Manufacturing Execution System In Life Sciences Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Manufacturing Execution System In Life Sciences Market
12.2.1. Germany Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.3. UK Global Manufacturing Execution System In Life Sciences Market
12.3.1. UK Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
12.3.3. UK Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
12.3.4. UK Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.4. France Global Manufacturing Execution System In Life Sciences Market
12.4.1. France Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
12.4.3. France Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
12.4.4. France Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Manufacturing Execution System In Life Sciences Market
12.5.1. Spain Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Manufacturing Execution System In Life Sciences Market
12.6.1. Italy Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Manufacturing Execution System In Life Sciences Market
12.7.1. Rest of Europe Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Manufacturing Execution System In Life Sciences Market
13.1. Asia Pacific Global Manufacturing Execution System In Life Sciences Market
13.1.1. Asia Pacific Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Manufacturing Execution System In Life Sciences Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Manufacturing Execution System In Life Sciences Market
13.2.1. Japan Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.3. China Global Manufacturing Execution System In Life Sciences Market
13.3.1. China Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
13.3.3. China Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
13.3.4. China Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.4. India Global Manufacturing Execution System In Life Sciences Market
13.4.1. India Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
13.4.3. India Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
13.4.4. India Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Manufacturing Execution System In Life Sciences Market
13.5.1. South Korea Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Manufacturing Execution System In Life Sciences Market
13.6.1. Australia Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Manufacturing Execution System In Life Sciences Market
13.7.1. Rest of Asia Pacific Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14. Latin America Global Manufacturing Execution System In Life Sciences Market
14.1. Latin America Global Manufacturing Execution System In Life Sciences Market
14.1.1. Latin America Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Manufacturing Execution System In Life Sciences Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Manufacturing Execution System In Life Sciences Market
14.2.1. Brazil Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Manufacturing Execution System In Life Sciences Market
14.3.1. Mexico Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Manufacturing Execution System In Life Sciences Market
14.4.1. Argentina Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Manufacturing Execution System In Life Sciences Market
14.5.1. Rest of Latin America Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. MEA Global Manufacturing Execution System In Life Sciences Market
15.1. MEA Global Manufacturing Execution System In Life Sciences Market
15.1.1. MEA Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Manufacturing Execution System In Life Sciences Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Manufacturing Execution System In Life Sciences Market
15.2.1. GCC Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Manufacturing Execution System In Life Sciences Market
15.3.1. South Africa Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Manufacturing Execution System In Life Sciences Market
15.4.1. Rest of MEA Manufacturing Execution System In Life Sciences Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Manufacturing Execution System In Life Sciences Market Size and Forecast, By Solution, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Manufacturing Execution System In Life Sciences Market Size and Forecast, By Deployment, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Manufacturing Execution System In Life Sciences Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. MasterControl Solutions, Inc.
17.2. Emerson Electric Co.
17.3. Körber AG
17.4. Rockwell Automation
17.5. iBase-t
17.6. ABB
17.7. Cognizant
17.8. AVEVA Group Limited
17.9. Siemens AG
17.10. nagarro
17.11. Other Prominent Players
18. Conclusion19. Recommendations

Companies Mentioned

  • MasterControl Solutions Inc.
  • Emerson Electric Co.
  • Körber AG
  • Rockwell Automation
  • iBase-t
  • ABB
  • Cognizant
  • AVEVA Group Limited
  • Siemens AG
  • nagarro